Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen
NCT04684615 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 193
Last updated 2026-05-05
Summary
People have had to make a lot of changes to their lives due to the COVID-19 health crisis. Most experts agree that social distancing and other safety measures have taken a toll on people s mental health. Amish and Mennonite communities often have large families. They may have limited access to health care. Their lifestyle is based on interaction and group events rather than technology. So people in Amish and Mennonite communities may experience the pandemic in their own special ways.
Objective:
To describe the relationship between stress related to the pandemic and self-rated measures of mental health symptoms and distress among Amish and Mennonite people with bipolar disorder and related conditions, and their family members.
Eligibility:
Adults ages 18 and older who are taking part in the NIMH AMBiGen study (80-M-0083).
Design:
Participants will be mailed 4 surveys. One survey will ask about depression symptoms. One survey will ask about mania symptoms. One survey will assess a broad range of psychological problems. One survey will assess the impact of COVID-19 on their mental health. They will fill out the surveys 4 times over 24 months.
The surveys will not include participants names, just codes. This will help protect privacy.
Data collected in 80-M-0083 will be used. This includes data about participants genes, medical conditions, and assessments.
Participants will get an 800 number they can call to speak to the research team. They can also write to the team if they prefer. Participants who wish will get referrals for mental health services. Participation will last up to 24 months. There will be an option for recontact in the future.
Conditions
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Principal Investigators
-
Francis J McMahon, M.D. · National Institute of Mental Health (NIMH)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-12-28
- Primary Completion
- 2025-05-15
- Completion
- 2025-05-15
Countries
- United States
Study Locations
More Related Trials
-
Bipolar Disorder Measures in Clinical Care
NCT05300919 ·Status: COMPLETED ·Phase: NA
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
NCT05457465 ·Status: RECRUITING ·Phase: PHASE2
-
Lamotrigine and Bupropion for Meniere's Disease
NCT05420350 ·Status: UNKNOWN ·Phase: PHASE2
-
Series Studies of Bipolar Disorder-Valproate add-on Memantine
NCT01188148 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Biological Classification of Mental Disorders
NCT03984084 ·Status: RECRUITING
-
Mood Stabilizer-induced Metabolic Abnormalities in Bipolar Disorder
NCT04486092 ·Status: UNKNOWN ·Phase: NA
-
Lamotrigine Therapy in Geriatric Bipolar Depression
NCT00720473 ·Status: COMPLETED ·Phase: NA
-
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
NCT01981811 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Trial of Mifepristone for Bipolar Depression
NCT00043654 ·Status: COMPLETED ·Phase: PHASE2
-
Reducing Cardiovascular Risk in Adults With Serious Mental Illness
NCT02451670 ·Status: COMPLETED ·Phase: NA
-
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
NCT03230097 ·Status: TERMINATED ·Phase: PHASE2
-
Disseminating Evidence-based Mood Disorder Chronic Care Models
NCT01615458 ·Status: COMPLETED ·Phase: NA
-
Antidepressant Treatments and Cognitive Function of Bipolar Patients
NCT04564573 ·Status: UNKNOWN
-
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
NCT02596698 ·Status: COMPLETED
-
Evaluation of the Genetics of Bipolar Disorder
NCT00001174 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
NCT00024635 ·Status: RECRUITING
-
Modeling Mood Course to Detect Markers for Effective Adaptive Interventions- Aim 3
NCT04098497 ·Status: COMPLETED ·Phase: PHASE1
-
Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder
NCT01126827 ·Status: COMPLETED ·Phase: NA
-
Memantine and Cognitive Dysfunction in Bipolar Disorder
NCT00586066 ·Status: COMPLETED ·Phase: PHASE4
-
Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting
NCT00237289 ·Status: COMPLETED ·Phase: PHASE3
-
Sleep Disturbance and Bipolar Disorder
NCT00993850 ·Status: COMPLETED ·Phase: PHASE3
-
Modeling Mood Course to Detect Markers of Effective Adaptive Interventions
NCT03358238 ·Status: COMPLETED ·Phase: NA
-
Effects of a Lifestyle Intervention on Body Mass Index in Patients With Bipolar Disorder
NCT00980863 ·Status: COMPLETED ·Phase: NA
-
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder
NCT06943573 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Genetics of COVID-19 Risks & Resilience in Bipolar Disorder
NCT04972708 ·Status: UNKNOWN